# Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis

Study · id `cardio:ct-nct04185571` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04185571](<https://clinicaltrials.gov/study/NCT04185571>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04185571

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.

## Technical summary

Registry record NCT04185571. Randomized; single masking; primary purpose treatment. Start 2011-07-12 (actual); primary completion 2021-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 106 participants (planned count; ClinicalTrials.gov record NCT04185571, source copy `cardio:ctgov-nct04185571-2019-12-04`, retrieved 2026-10-26)
- Started: 2011-07-12 (actual) (ClinicalTrials.gov record NCT04185571, source copy `cardio:ctgov-nct04185571-2019-12-04`, retrieved 2026-10-26)
- Primary completion: 2021-04 (anticipated) (ClinicalTrials.gov record NCT04185571, source copy `cardio:ctgov-nct04185571-2019-12-04`, retrieved 2026-10-26)
- Completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT04185571, source copy `cardio:ctgov-nct04185571-2019-12-04`, retrieved 2026-10-26)
- Countries: France; Monaco (ClinicalTrials.gov record NCT04185571, source copy `cardio:ctgov-nct04185571-2019-12-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04185571-2019-12-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Influence of the PEPA Membrane on the Undernutrition Syndrome Inflammation in Chronic Hemodialysis
- Acronym: NutriPEPA2
- Condition: ESRD
- Intervention (Device): PEPA
- Lead sponsor: Theradial
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: b0fe0ad73b6e94a4dad200d63a63ccbc3e8efe39deaea705002f9778c5166973
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
